In another recent study, the receptor-like protein tyrosine phosphatase eta (CD148/PTPRJ) mediated by its ligand syndecan-2 (SDC2) has been shown to also have anti-fibrotic effects in murine and human models of IPF. This evidence concerns the gene PTPRJ and idiopathic pulmonary fibrosis.